Bacterial cell wall structures, intracellular enzymes, and inflammatory mediators

This entry represents a broad grouping of therapeutic targets involved in the pathogenesis of bacterial infections and the subsequent host immune response. Bacterial cell wall structures, specifically peptidoglycan, are essential for maintaining the structural integrity of bacteria and are the primary targets for bactericidal agents like beta-lactams and glycopeptides (StatPearls, 2023). Intracellular enzymes, such as DNA gyrase, RNA polymerase, and various metabolic enzymes, are critical for bacterial replication and survival, serving as targets for fluoroquinolones and rifamycins (PubMed, 2021). Inflammatory mediators, including cytokines (TNF-alpha, IL-1, IL-6) and prostaglandins, are produced by the host in response to bacterial components like lipopolysaccharides (LPS) and are targeted to manage sepsis or chronic inflammatory conditions (Nature Reviews Immunology, 2020). The clinical significance of these targets lies in their dual role: direct eradication of the pathogen and the modulation of the host's potentially deleterious inflammatory cascade. Because this term combines multiple distinct molecular entities across different organisms (host and pathogen), it is classified as a composite category rather than a single specific target (NIH, 2022).

Other names

Bacterial targets and host inflammatory factorsAntimicrobial and anti-inflammatory target complexPathogen-associated molecular patterns and host response mediators

Inhibition of bacterial cell wall cross-linking (peptidoglycan synthesis), inhibition of bacterial nucleic acid or protein synthesis, and modulation or antagonism of host inflammatory signaling pathways.